Evidence that an HMGA1 gene variant associates with type 2 diabetes, body mass index, and high-density lipoprotein cholesterol in a Hispanic-American population

Metabolic Syndrome and Related Disorders

Volumn 12, Issue 1, 2014, Pages 25-30

  Pullinger, Clive R ^a   Goldfine, Ira D ^b   Tanyolaç, Sinan ^c   Movsesyan, Irina ^a   Faynboym, Mark ^d   Durlach, Vincent ^e   Chiefari, Eusebio ^f   Foti, Daniela P ^f   Frost, Philip H ^a   Malloy, Mary J ^a   Brunetti, Antonio ^f   Kane, John P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ISTANBUL BILIM UNIVERSITY   (Turkey)

^d City College of SF   (United States)

^e SERVICE DE DERMATOLOGIE   (France)

^f UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HIGH MOBILITY GROUP A1A PROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; HEART INFARCTION; HISPANIC; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

ADIPOSITY; AGED; ANTHROPOMETRY; BODY MASS INDEX; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC VARIATION; GENOTYPE; HISPANIC AMERICANS; HMGA1A PROTEIN; HUMANS; INSULIN RESISTANCE; LIPIDS; LIPOPROTEINS; MALE; MEXICO; MIDDLE AGED; RECEPTOR, INSULIN; RETROSPECTIVE STUDIES;

EID: 84892557704     PISSN: 15404196     EISSN: 15578518     Source Type: Journal    
DOI: 10.1089/met.2013.0086     Document Type: Article

References (28)

1. Centers for Disease Control and Prevention. National diabetes fact sheet: National estimates and general information on diabetes and prediabetes in the United States. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2011
2. Hayes MG, Pluzhnikov A, Miyake K, et al. Identification of type 2 diabetes genes in Mexican Americans through genome-wide association studies. Diabetes 2007;56:3033-3044 (Pubitemid 350223640)
3. Cornier M-A, Dabelea D, Hernandez TL, et al. The metabolic syndrome. Endocr Rev 2008;29:777-822
4. Chiefari E, Iiritano S, Paonessa F, et al. Pseudogene-mediated posttranscriptional silencing of HMGA1 can result in insulin resistance and type 2 diabetes. Nat Commun 2010;1:40
5. Chiefari E, Tanyolaç S, Iiritano S, et al. A polymorphism of HMGA1 is associated with increased risk of metabolic syndrome and related components. Sci Rep 2013;3:1-6
6. Chiefari E, Tanyolaç S, Paonessa F, et al. Functional variants of the HMGA1 gene and type 2 diabetes mellitus. JAMA2011;305:903-912
7. Foti D, Chiefari E, Fedele M, et al. Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice. Nat Med 2005;11:765-773 (Pubitemid 41021209)
8. Foti D, Iuliano R, Chiefari E, et al. A nucleoprotein complex containing Sp1, C/EBP beta, and HMGI-Y controls human insulinreceptor gene transcription.MolCellBiol 2003;23:2720-2732 (Pubitemid 36403073)
9. Liu L, Ding H, Wang HR, et al. Polymorphism of HMGA1 is associated with increased risk of type 2 diabetes among Chinese individuals. Diabetologia 2012;55:1685-1688
10. Bustin M, Reeves R. High-mobility-group chromosomal proteins: Architectural components that facilitate chromatin function. Prog Nucleic Acid Res Mol Biol. 1996;54:35-100
11. Karnes JH, Langaee TY, McDonough CW, et al. Lack of association of the HMGA1 IVS5-13insC variant with type 2diabetes in an ethnically diverse hypertensive case control cohort. J Transl Med 2013;11:12
12. Marquez M, Huyvaert M, Perry JRB, et al. Low-frequency variants in HMGA1 are not associated with type 2 diabetes risk. Diabetes 2012;61:524-530
13. Guey LT, Pullinger CR, Ishida BY, et al. Relation of increased prebeta-1 high-density lipoprotein levels to risk of coronary heart disease. Am J Cardiol 2011;108:360-366
14. Kane JP, Malloy MJ, Ports TA, et al. Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. JAMA 1990;264: 3007-3012
15. Pullinger C.R., Hennessy L.K., Chatterton J.E., et al. Familial ligand-defective apolipoprotein B - Identification of a new mutation that decreases LDL receptor binding affinity. J Clin Invest 1995, 95:1225-1234
16. Warnick GR, Benderson J, Albers JJ. Dextran sulfate-Mg2 +precipitation procedure for quantitation of high-densitylipoprotein cholesterol. Clin Chem 1982;28:1379-1388 (Pubitemid 12125081)
17. Havel RJ, Eder H, Bragdon J. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955;34:1345-1353
18. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502
19. Heo M, Kabat GC, Gallagher D, et al. Optimal scaling of weight and waist circumference to height for maximal association with DXA-measured total body fat mass by sex, age and race/ethnicity. Int J Obes (Lond) 2013;37: 1154-1160
20. Myers LH, Phillips NR, Havel RJ. Mathematical evaluation of methods for estimation of the concentration of the major lipid components of human serum lipoproteins. J Lab Clin Med 1976;88:491-505
21. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-3421
22. Rich SS, Goodarzi MO, Palmer ND, et al. A genome-wide association scan for acute insulin response to glucose in Hispanic-Americans: The Insulin Resistance Atherosclerosis Family Study (IRAS FS). Diabetologia 2009;52:1326-1333
23. Yeni-Komshian H, Carantoni M, Abbasi F, et al. Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers. Diabetes Care2000;23:171-175 (Pubitemid 30071019)
24. Altman DG, Deeks JJ, Sackett DL. Odds ratios should be avoided when events are common. BMJ 1998;317:1318 (Pubitemid 28502424)
25. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology 1990;1:43-46 (Pubitemid 20255621)
26. Fontana L, Klein S, Holloszy JO. Effects of long-term calorie restriction and endurance exercise on glucose tolerance, insulin action, and adipokine production. Age (Dordr) 2010; 32:97-108
27. Kashyap SR, Defronzo RA. The insulin resistance syndrome: Physiological considerations. Diab Vasc Dis Res 2007;4:13-19 (Pubitemid 46649069)
28. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607